Clovis Oncology Inc (NASDAQ:CLVS)

3.66
Delayed Data
As of 4:00pm ET
 +0.46 / +14.38%
Today’s Change
3.01
Today|||52-Week Range
32.05
-79.62%
Year-to-Date
3 Beaten-Up Biotechs -- Are They Buys?
Oct 13 / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Oct 10 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content
Clovis Gains Rights to Pre-Clinical Cancer Program for $12M
Sep 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close3.20
Today’s open3.26
Day’s range3.21 - 3.76
Volume3,891,968
Average volume (3 months)3,346,428
Market cap$179.0M
Data as of 4:00pm ET, 10/17/2019

Growth & Valuation

Earnings growth (last year)+3.97%
Earnings growth (this year)-6.57%
Earnings growth (next 5 years)+31.35%
Revenue growth (last year)+71.84%
P/E ratioNM
Price/Sales9.80
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.01+0.45%
RDHLRedhill Biopharma Lt...+0.08+1.31%
ACSTAcasti Pharma Inc+0.04+1.87%
NERVMinerva Neuroscience...-0.06-1.40%
Data as of 4:00pm ET, 10/17/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$1.89
Annual revenue (last year)$95.4M
Annual profit (last year)-$368.0M
Net profit margin-385.80%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts